GLP-1 Tribe

Why Keeping Muscle Matters More Than You Think! GLP-1 Weight Loss: A Strength Training Guide to Preserve Muscle This podcast offers guidance on integrating strength training while on a weight loss journey that utilizes GLP-1 medications like Ozempic, Zepbound and Wegovy. We highlight the tendency for individuals on these medications to lose muscle mass alongside fat and emphasize the critical role...

GLP-1 Medications: 10 Major Health Benefits Beyond Weight Loss GLP-1 receptor agonist medications , such as Wegovy, Ozempic, Mounjaro, and Zepbound, initially developed for diabetes, offer substantial health benefits extending beyond weight loss. These "non-scale victories" include improvements in cardiovascular health , such as blood pressure and cholesterol, reduced inflammation , and...

Your Body, Your Journey, Your Conversation: Navigating Social Life While Taking GLP-1 Weight Loss Medications This episode explores the multifaceted experience of individuals using GLP-1 medications for weight loss, addressing the significant physical and internal changes that occur. We highlight the common challenge of navigating social conversations about this visible transformation, focusing on...

Wegovy & Zepbound: Overcoming Weight Loss Plateaus The podcast explain that weight loss plateaus are a common occurrence for individuals using GLP-1 medications like Wegovy and Zepbound.  But there is a way to continue to get great progress and results.    These medications, which mimic gut hormones to suppress appetite and slow digestion, initially lead to significant weight loss, but the bod...

This episode offers guidance on maximizing weight loss while using the medications Wegovy and Zepbound. It highlights that while these GLP-1 receptor agonists are effective for weight reduction, individual results vary. The article presents ten evidence-based strategies focusing on diet, hydration, exercise (both cardio and strength training), sleep, stress management, and consistent communication...

Compounded semaglutide and tirzepatide provided a vital stopgap during shortages, but their role has come under scrutiny as supply stabilizes. While affordability remains a pressing issue—particularly for those without insurance coverage—the risks of inconsistent quality, contamination, and adverse effects cannot be ignored. With pharmaceutical giants like Eli Lilly pushing for tighter restriction...

These sources offer a comprehensive overview of accessing GLP-1 medications for individuals in the United States who rely on Medicaid and Medicare .  The Centers for Medicare & Medicaid Services said this week it did not move forward with a proposal put forth by the Biden administration for Medicare coverage of weight-loss drugs such as Novo Nordisk's Wegovy. They highlight the complexiti...

GLP-1 Insurance Coverage Strategies:  This podcast synthesizes information from 100+ sources on navigating private insurance coverage for Glucagon-like peptide-1 (GLP-1) receptor agonists in the US. These medications are increasingly important for managing type 2 diabetes and chronic weight management but often face coverage challenges due to their high cost and varying insurance policies. The pod...

GLP-1 receptor agonists have rapidly transformed the landscape of diabetes and weight management treatment in the United States and globally. Initially approved for type 2 diabetes, these medications—including brands like Ozempic, Wegovy, Mounjaro, and Zepbound—have gained widespread attention for their effectiveness in both glycemic control and significant weight loss. This article examines the c...

This report synthesizes information from 100+ sources regarding the significant price disparities for Glucagon-Like Peptide-1 (GLP-1) receptor agonists (e.g., Wegovy, Ozempic, Zepbound, Mounjaro) between the United States and other developed countries like Canada, the United Kingdom, and nations within the European Union (primarily Germany and France).  The analysis reveals that the higher costs i...

GLP-1 Medication Nausea: Management Strategies and Tips The episode extensively explores the common side effect of nausea experienced by 50% individuals using GLP-1 medications for type 2 diabetes and weight loss. We explain why nausea occurs , detailing the medication's impact on gastric emptying and brain signaling. The sources offer a range of management strategies , including dietary adju...

In this episode we discuss daily, weekly and monthly exercise impact for patients on  GLP-1 medicines like Wegovy, Ozempic, and Zepbound, explaining how exercise aids in weight loss and blood sugar control. We emphasize that physical activity is crucial for maximizing the benefits of these medications, including enhanced weight loss, muscle preservation, and improved cardiovascular health. While 1...

In this episode we explore if drinking more water is the secret to losing more weight on a GLP-1 like Ozempic, Wegovy or Zepbound. Drinking more water helps you lose more weight because: Reduces side effects from GLP-1 medications (especially constipation and nausea) Helps maintain energy levels and cognitive function Supports kidney function for processing medications Promote healthy digestion Su...

The duration of GLP-1 medication use is often long-term for both type 2 diabetes and weight management, with many patients continuing on these medications in a "maintenance mode" after achieving initial treatment goals. This maintenance phase is crucial for sustaining weight loss, maintaining glycemic control, and potentially realizing the cardioprotective and renoprotective benefits ass...

This podcast explain the connection between GLP-1 medications, such as Ozempic and Wegovy, and hair loss experienced by some users. The research and science clarifies that hair loss is often a temporary condition, primarily resulting from the physiological stress of rapid weight loss and potential nutrient deficiencies rather than a direct effect of the drugs. The sources offer expert guidance and...

It this episode we explore the concepts of " slow responders " and " super responders ," to GLP-1 medicines defining them based on the degree of weight loss achieved.  The podcast discussed a multitude of factors contributing to this variability, including individual biological differences , such as genetics, body composition, and gut microbiome, as well as medication-related a...

This episode explores the emerging role of GLP-1 medications beyond diabetes and weight management, highlighting their potential to combat inflammation . These drugs, originally developed for blood sugar control, are showing promise in treating conditions like A rthritis, Parkinson's, and Alzheimer's disease by modulating immune responses and reducing inflammatory pathways. Research indi...

America's Weight: Obesity Crisis and GLP-1 Medications In this episode we highlight the serious and widespread obesity crisis affecting both adults and children in America, evidenced by alarming prevalence rates and significant negative impacts on health, the economy, and even national security .  The podcast explore potential solutions , with a particular focus on GLP-1 medications as a prom...

Gallbladder Health: Rapid Weight Loss, GLP-1s, and Living Without a Gallbladder This podcast explains that gallbladder issues, including gallstones, are common and can be exacerbated by rapid weight loss , such as that experienced with GLP-1 medications like Ozempic and Wegovy. Rapid weight loss can increase cholesterol in bile and reduce gallbladder emptying , increasing the risk of gallstone for...

There is a mega trend on social media of people discussing microdosing Ozempic, Wegovy and GLP-1 medications.  Some experts suggest microdosing is better for patients because the prescribed doses are over medicating patients. What are the pros and cons of microdosing? GLP-1 Microdosing: Trends, Evidence, and Safety Concerns We explore the emerging trend of microdosing GLP-1 receptor agonists , suc...

This podcast emphasizes the importance of comprehensive health tracking for individuals using GLP-1 medications, highlighting its role in motivation, early issue detection, personalization, and provider collaboration . It details various methods for monitoring activity, weight, nutrition, sleep, glucose, and cardiac health , recommending tools like smartwatches, scales, food diary apps, sleep trac...

The landscape of medications for weight management and type 2 diabetes has evolved significantly, with semaglutide and tirzepatide emerging as prominent options that have garnered considerable attention from patients and healthcare professionals alike . If you are navigating the complexities of managing your weight or blood sugar, you've likely encountered these two medications. This podcast...

Imagine a constant hum in the background of your mind, a radio station perpetually tuned to thoughts of food. Even after a satisfying meal, the mental chatter persists: What will you eat next? Should you grab a snack? That's "food noise" – a pervasive preoccupation with food that can dominate thoughts and make it difficult to focus on anything else . For many, this isn't just o...

GLP-1 Medications: Weight Loss and Heart Health Protection If you’re living with obesity, high blood pressure, or diabetes, you may worry about your heart. The good news is that new weight loss medications like Wegovy® and Zepbound™ (GLP-1 receptor agonists) can do more than help shed pounds – they may actually protect your heart . In this friendly guide, we’ll explore how these treatments work an...

The evidence strongly suggests that GLP-1 medications, particularly tirzepatide, hold significant promise in reducing the severity of obstructive sleep apnea in individuals with obesity. Clinical trials and meta-analyses have demonstrated substantial reductions in the Apnea-Hypopnea Index (AHI), along with significant weight loss and improvements in related cardiometabolic risk factors. The recent...